Since the two encapsulation techniques presented adequate physicochemical features and similar association efficiency, both formulations were tested for cell toxicity in HCT116 and MDA-MB-231 colon and breast cancer cells, to evaluate whether the level of exposure to Ab-SMC2 might affect its in vitro efficacy. The gene discussed is SMC2; the disease is breast cancer.